Trial intelligence / Profile preview

Ferinject in non-anemic premenopausal women with low ferritin

NCT01374776Phase 4Completed

Sponsor
University of Zurich
Start
Feb 2013
Primary completion
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by University of Zurich. Started Feb 2013; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT01374776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01374776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call